Home > Research Areas > Metabolic Disorder
Cat. No. Product name CAS No.
DC8041 MK-0941 Featured

MK-0941 is a novel Glucokinase activator (GKA)

1137916-97-2
DC7585 Omarigliptin Featured

MK-3102 (MSD) is a novel DPP-4 Inhibitor, which improves glycaemic control with low risk of symptomatic hypoglycaemia.

1226781-44-7
DC5034 MK8245 Featured

MK-8245 is an liver-targeting inhibitor of stearoyl-CoA desaturase (SCD) with IC50 of 1 nM for human SCD1 and 3 nM for both rat SCD1 and mouse SCD1, with anti-diabetic and anti-dyslipidemic efficacy.

1030612-90-8
DC12020 MK-8722 Featured

MK-8722 is a systemic, Direct Pan-Activator of AMP-Activated Protein Kinase.

1394371-71-1
DC12255 MLN-4760 Featured

MLN-4760 is a potent and selective human ACE2 inhibitor (IC50, 0.44 nM), with excellent selectivity (>5000-fold) versus related enzymes including human testicular ACE (IC50, >100 μM) and bovine carboxypeptidase A (CPDA; IC50, 27 μM).

305335-31-3
DC4136 NPS-2143 HCL

NPS 2143 hydrochloride is a selective CaSR (Ca2+-sensing receptor) inhibitor and antagonist, shown to block increases in cytoplasmic Ca2+ concentrations elicited by human Ca2+ receptors expressed in HEK293 cells with an IC50 of 43 nM. NPS 2143 hydrochlori

324523-20-8
DC7214 NPS-2143(SB 262470A )

NPS-2143(SB 262470A ) is a selective potent calcium ion-sensing receptor antagonist with IC50 of 43 and 41 nM for cytoplasmic Ca2+ concentrations and parathyroid hormone secretion, respectively.

284035-33-2
DC10807 O304 Featured

O304 is a novel AMPK activator.

1261289-04-6
DC6401 Odanacatib (MK 0822) Featured

Odanacatib (MK 0822) is a potent, selective, and neutral inhibitor of human and rabbit cathepsin K with IC50 of 0.2 nM and 1 nM , respectively.

603139-19-1
DC7109 Otenabant (CP-945598 free base) Featured

Otenabant (CP945598) is a recently discovered selective, high affinity, competitive CB1 receptor antagonist with Ki of 0.7 nM.

686344-29-6
DC7227 PF-04620110 Featured

PF-04620110 is an orally active, selective and potent diglyceride acyltransferase-1 (DGAT1) inhibitor with IC50 of 19 nM.

1109276-89-2
DC3108 PF-04971729 (Ertugliflozin) Featured

PF-04971729 is a potent and selective inhibitor of the sodium-dependent glucose cotransporter 2, is currently in phase 2 trials for the treatment of diabetes mellitus.

1210344-57-2
DC10050 PF05175157 Featured

PF-05175157 is a potent and selective inhibitor of both acetyl-CoA carboxylase isoform ACC1 located primarily in liver and adipose tissue and isoform ACC2 dominant in skeletal and heart muscle, with IC50 values of 27 nM and 33 nM, respectively.

1301214-47-0
DC11466 PF-06409577 Featured

PF-06409577 is a potent and selective allosteric activator of AMPK α1β1γ1 isoform with an EC50 of 7 nM.

1467057-23-3
DC9454 Ro 28-1675

Ro 28-1675 (Ro 0281675) is a potent allosteric GK activator with a SC1.5 value of 0.24± 0.0019 uM.

300353-13-3
DC9084 Rosiglitazone base

Rosiglitazone(BRL-49653) is a high-affinity selective agonist of the peroxisome proliferator-activated receptor-γ(PPARγ).

122320-73-4
DC8875 Saxagliptin Featured

Saxagliptin is a selective and reversible DPP4 inhibitor with IC50 of 26 nM and Ki of 1.3 nM.

361442-04-8
DC7495 SB-334867 HCl Featured

SB-334867 is a selective non-peptide orexin OX1 receptor antagonist with a pKb value of 7.2.

249889-64-3
DC8419 SB-334867 Featured

SB-334867 is a selective orexin-1 (OX1) receptor antagonist.

792173-99-0
DC9690 Sinogliatin (HMS5552, RO5305552) Featured

Sinogliatin (HMS5552, RO5305552) is a mall molecule glucokinase (GCK; GK) activator.

1191996-10-7
DCAPI1445 strontium ranelate

Strontium Ranelate is a bone metabolism modulator that inhibits bone resorption while maintaining bone formation. Commonly used as an antiosteoporotic.

135459-87-9
DC10581 Succinobucol(AGI 1067) Featured

Succinobucol is a phenolic antioxidant with anti-inflammatory and antiplatelet effects.

216167-82-7
Page 3 / Total 4 FirstPrevNextLastGoto